Disclaimer
Copyright MSCI [Year data was provided to Licensee].Unpublished. All Rights Reserved. This information may only be used for your internal non-commercial use, and may not be used, reproduced or redisseminated in any form, for any other purpose, including without limitation creating any financial instruments or products or indices. None of this information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. This information is provided on an “as is” basis and the user of this information assumes the entire risk of any use it may make or permit to be made of this information. Neither MSCI, any or its affiliates or any other person involved in or related to compiling, computing or creating this information makes any express or implied warranties or representations with respect to such information or the results to be obtained by the use thereof, and MSCI, its affiliates and each such other person hereby expressly disclaim all warranties (including, without limitation, all warranties of originality, accuracy, completeness, timeliness , non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any other person involved in or related to compiling, computing or creating this information have any liability for any direct, indirect, special, incidental, punitive, consequential or any other damages (including, without limitation, lost profits) even if notified of, or if it might otherwise have anticipated, the possibility of such damages. |
- Budget 2016: How Modi's infra team is implementing its agenda
- From the horse's mouth: 5 reforms that will jumpstart infra
- RBI rate cut may propel Nifty; trading in mkt positive: Udayan
- Govt to unveil new defence policy on Mar 28, effective Apr 1
- Oct-Dec CAD drops to 1.3%, BoP surplus at $4.1bn
- Sharepro fraud widens; Britannia latest to be hit by share theft
- Midcaps leading economic recovery: BNP fund manager
- Sukla Chandra on India's R&D quotient
Market Watch
Price | Chg | %Chg | |
---|---|---|---|
Nifty | 7704.25 | 99.90 | 1.31% |
Sensex | 25285.37 | 332.63 | 1.33% |
SGX Nifty | 7724.00 | 13.00 | 0.17% |
CNXMidcap | 12565.90 | 160.40 | 1.29% |
Bank Nifty | 15926.10 | 271.25 | 1.73% |
BSESmallcap | 10448.48 | 139.72 | 1.36% |
Price | Chg | %Chg | |
---|---|---|---|
India (USD) | 733.47 | 15.94 | 2.22% |
EM | 2034.15 | 33.52 | 1.68% |
ACWI | 764.54 | 9.33 | 1.24% |
AC Asia ex Japan |
1142.00 | 11.88 | 1.05% |
* Delayed Value
Management Speak
News Ticker
Sun Pharma :
Imatinib Mesylate Is Therapeutic Equivalent To GleevecSun Pharma :
Launches Imatinib Mesylate In USBalaji Tele :
To Mull Fundraising Via Issue Of Securities On Pref Basis On February 4
Your View
@CNBCTV18News
CNBC-TV18 Shows